Table of Content


Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown

Chapter 2 Summary and Highlights
Market Outlook
Market Summary

Chapter 3 Market Overview
Introduction
Benefits of Biologics CDMOs
Expertise
Equipment and Manufacturing Facilities
Scalability
Benefits of Outsourcing
Drawbacks to Outsourcing
Contract Manufacturing
Types of Contract Manufacturers
Evolution of Contract Manufacturing Organizations
Outsourcing
Criteria for Evaluating a Contract Manufacturer
Core Capabilities of CMOs
Core Functional Areas Requiring Constant Attention
Criteria for Selecting an Outsourcing Partner
Top Sources of Dissatisfaction
Challenges in Contract Manufacturing
Services Offered by CMOs
Contract Research
Selecting a CRO
Services Offered by CROs
Checklist for Selecting a CRO
Benefits of Using a CRO
Client/CRO Relationship

Chapter 4 Market Dynamics
Market Drivers
Rising Prevalence of Cancer
Increasing Demand for Biologics
Rising Use of CDMOs
Increasing Elderly Population
Market Restraints
Biologic Product Costs and Price Controls
Capacity Constraints
Manufacturing Costs
Market Opportunities
Co-development of Biosimilars

Chapter 5 Global Market for Biologics CDMOs by Product Type
Introduction
Biologics
Biosimilars
Biologics
Biosimilars

Chapter 6 Global Market for Biologics CDMOs by Cell-Line Type
Mammalian
Microbial (Non-mammalian)
Other Modalities

Chapter 7 Global Market for Biologics CDMOs by Region
Market Overview and Discussion
North America
Europe
Asia-Pacific
RoW

Chapter 8 Sustainability in Biologics CDMOs: An ESG Perspective
Introduction to ESG
Sustainability in Biologics CDMO Industry: An ESG Perspective
Key ESG Issues
Attitudes toward ESG
Industry ESG Performance Analysis
Toyobo and ESG

Chapter 9 Emerging Technologies and Developments
Overview
Big Data, AI and ML
Single-use Technology
Process Analytical Technology (PAT)

Chapter 10 Regulatory Landscape
Regulation of Biologics Services
FDA Regulations
European Regulations
Impact of FDA Regulations
The Declaration of Helsinki
CDISC Standards

Chapter 11 M&A and Venture Funding Outlook
M&A Analysis
Recent News

Chapter 12 Competitive Intelligence

Chapter 13 Company Profiles
ABBVIE PHARMACEUTICAL CONTRACT MANUFACTURING
AGC BIOLOGICS
BOEHRINGER INGELHEIM BIOXCELLENCE
BINEX CO. LTD.
BIOVIAN OY
BORA PHARMACEUTICAL CDMO
CATALENT INC
CYTOVANCE BIOLOGICS
EMERGENT BIOSERVICES
FUJIFILM DIOSYNTH BIOTECHNOLOGIES
ICON PLC
JRS PHARMA GMBH & CO. KG
KEMWELL
LONZA GROUP
LOTTE BIOLOGICS
PAREXEL INTERNATIONAL CORP.
RENTSCHLER BIOPHARMA SE
SAMSUNG BIOLOGICS
SANDOZ INTERNATIONAL GMBH
THERMO FISHER SCIENTIFIC INC.
TOYOBO CO. LTD.
WUXI XDC

Chapter 14 Appendix



List of Figures



Summary Figure A : Global Market for Biologics CDMOs, by Region, 2020-2028
Summary Figure B : Global Market Shares of Biologics CDMOs, by Region, 2022
Figure 1 : Role of Contract Service Providers in the Pharmaceutical Value Chain
Figure 2 : CDMO Services
Figure 3 : Global Market for Biologics CDMOs, by Product Type, 2020-2028
Figure 4 : Global Market Shares of Biologics CDMOs, by Product Type, 2022
Figure 5 : Global Market for Biologics, by Region, 2020-2028
Figure 6 : Global Market Shares of Biologics, by Region, 2022
Figure 7 : Global Market for Biosimilars, by Region, 2020-2028
Figure 8 : Global Market Shares of Biosimilars, by Region, 2022
Figure 9 : Global Market for Biologics CDMOs, by Cell-Line Type, 2020-2028
Figure 10 : Global Market Shares of Biologics CDMOs, by Cell-Line Type, 2022
Figure 11 : Global Market for Mammalian Biologics CDMOs, by Region, 2020-2028
Figure 12 : Global Market Shares of Mammalian Biologics CDMOs, by Region, 2022
Figure 13 : Global Market for Microbial Biologics CDMOs, by Region, 2020-2028
Figure 14 : Global Market Shares of Microbial Biologics CDMOs, by Region, 2022
Figure 15 : Global Market for Other Modalities for Biologics CDMOs, by Region, 2020-2028
Figure 16 : Global Market Shares of Other Modalities for Biologics CDMO, by Region, 2022
Figure 17 : Global Market for Biologics CDMOs, by Region, 2020-2028
Figure 18 : Global Market Shares of Biologics CDMOs, by Region, 2022
Figure 19 : North American Market for Biologics CDMOs, by Country, 2020-2028
Figure 20 : North American Market Shares of Biologics CDMOs, by Country, 2022
Figure 21 : European Market for Biologics CDMOs, by Country, 2020-2028
Figure 22 : European Market Shares of Biologics CDMOs, by Country, 2022
Figure 23 : Asia-Pacific Market for Biologics CDMOs, by Country, 2020-2028
Figure 24 : Asia-Pacific Market Shares of Biologics CDMOs, by Country, 2022
Figure 25 : How A Strong ESG Proposition Can Benefit Businesses
Figure 26 : Level of ESG Adoption across All Industries
Figure 27 : Business Sustainability Trends
Figure 28 : Toyobo Co. Ltd. ESG Focus Areas
Figure 29 : Emerging Technologies in the Biologics CDMO Market
Figure 30 : FDA cGMP Manufacturing Guidance Documents
Figure 31 : FDA Site Inspections
Figure 32 : European cGMP Guideline Documentation
Figure 33 : European Site Inspection Outcomes
Figure 34 : Boehringer Ingelheim: Revenue Share, by Business, 2022
Figure 35 : Boehringer Ingelheim: Revenue Share, by Region, 2022
Figure 36 : Bora Pharmaceutical: Revenue Share, by Product, 2022
Figure 37 : Bora Pharmaceutical: Revenue Share, by Region, 2022
Figure 38 : Catalent Inc.: Revenue Share, by Business Segment, 2022
Figure 39 : Catalent Inc.: Revenue Share, by Region, 2022
Figure 40 : Emergent Biosolutions: Revenue Share, by Segment, 2022
Figure 41 : Emergent Biosolutions: Revenue Share, by Region, 2022
Figure 42 : ICON plc: Company Revenue, 2020-2022
Figure 43 : Icon plc: Revenue Share, by Region, 2022
Figure 44 : Lonza: Revenue Share, by Operating Segment, 2022
Figure 45 : Lonza: Revenue Share, by Region, 2022
Figure 46 : Samsung Biologics: Revenue Share, by Operating Segment, 2022
Figure 47 : Sandoz: Revenue Share, by Business Segment, 2022
Figure 48 : Sandoz: Revenue Share, by Region, 2022
Figure 49 : Thermo Fisher Scientific Inc.: Revenue, 2020-2022
Figure 50 : Thermo Fisher Scientific Inc.: Revenue Share, by Segment, 2022
Figure 51 : Thermo Fisher Scientific Inc.: Revenue Share, by Segment, 2022
Figure 52 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022
Figure 53 : Toyobo Co. Ltd.: Revenue Share, by Operating Segment, 2022
Figure 54 : WuXi Biologics: Company Revenue, 2020–2022
Figure 55 : WuXi Biologics: Revenues by Goods and Services, 2020–2022
Figure 56 : WuXi Biologics: Revenue Share, by Region, 2020–2022

List of Tables



Summary Table : Global Market for Biologics CDMOs, by Region, Through 2028
Table 1 : 65-and Over Population, by Region, 2019 And 2050
Table 2 : Global Market for Biologics CDMOs, by Product Type, Through 2028
Table 3 : Global Market for Biologics, by Region, Through 2028
Table 4 : Global Market for Biosimilars, by Region, Through 2028
Table 5 : Global Market for Biologics CDMOs, by Cell-Line Type, Through 2028
Table 6 : Global Market for Mammalian Biologics CDMOs, by Region, Through 2028
Table 7 : Global Market for Microbial Biologics CDMOs, by Region, Through 2028
Table 8 : Global Market for Other Modalities for Biologics CDMOs, by Region, Through 2028
Table 9 : Global Market for Biologics CDMOs, by Region, Through 2028
Table 10 : North American Market for Biologics CDMOs, by Country, Through 2028
Table 11 : European Market for Biologics CDMOs, by Country, Through 2028
Table 12 : Asia-Pacific Market for Biologics CDMOs, by Country, Through 2028
Table 13 : RoW Market for Biologics CDMOs, Through 2028
Table 14 : Key Focus Areas in ESG Metrics
Table 15 : Net-Zero GHG Commitments, by Major Biologics CDMOs
Table 16 : ESG Rankings for Major Biologics CDMO Companies, 2023*
Table 17 : CDP’s Scope Card for Major Biologics CDMO Companies, 2022
Table 18 : Ranking of Biologics CDMOs
Table 19 : Boehringer Ingelheim: Revenue, 2020-2022
Table 20 : Boehringer Ingelheim: Revenue, by Business, 2020-2022
Table 21 : Boehringer Ingelheim: Revenue, by Region, 2020-2022
Table 22 : Bora Pharmaceutical: Revenue, 2021 and 2022
Table 23 : Bora Pharmaceutical: Revenue, by Product, 2021 and 2022
Table 24 : Bora Pharmaceutical: Revenue, by Region, 2021 and 2022
Table 25 : Catalent Inc.: Revenue, 2020 and 2022
Table 26 : Catalent Inc.: Revenue, by Business Segment, 2020-2022
Table 27 : Catalent Inc.: Revenue, by Region, 2020-2022
Table 28 : Emergent Bioservices: Development and Manufacturing Services
Table 29 : Emergent Biosolutions: Revenue, by Segment, 2021 and 2022
Table 30 : Emergent Biosolutions: Revenue, by Region, 2021-2022
Table 31 : FujiFilm Diosynth Biotechnologies: Services
Table 32 : ICON plc: Revenue, by Region, 2020-2022
Table 33 : Lonza: Revenue, 2020-2022
Table 34 : Lonza: Revenue, by Operating Segment, 2020-2022
Table 35 : Lonza: Revenue Share, by Region, 2020-2022
Table 36 : Samsung Biologics: Revenue, 2020-2022
Table 37 : Samsung Biologics: Revenue, by Operating Segment, 2020-2022
Table 38 : Sandoz: CDMO Services Across Technology Segments
Table 39 : Sandoz: Revenue, 2020-2022
Table 40 : Sandoz: Revenue, by Business Segment, 2020-2022
Table 41 : Sandoz: Revenue, by Region, 2020-2022
Table 42 : Thermo Fisher Scientific Inc.: Revenue, by Segment
Table 43 : Thermo Fisher Scientific Inc.: Revenue, by Segment
Table 44 : Thermo Fisher Scientific Inc.: Revenue, by Region
Table 45 : Toyobo Co. Ltd.: Revenue, 2020-2022
Table 46 : WuXi Biologics: Products and Services
Table 47 : WuXi Biologics: Revenues by Goods and Services, 2020-2022
Table 48 : WuXi Biologics: Revenue, by Region, 2020-2022
Table 49 : Acronyms